| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/08/1998 | DE19624705A1 Dendrimere auf Saccharid-Basis Saccharide-based dendrimers |
| 01/08/1998 | CA2259557A1 Non-aqueous polar aprotic peptide formulations |
| 01/08/1998 | CA2259505A1 Aqueous formulations of peptides |
| 01/08/1998 | CA2259403A1 Non-aqueous protic peptide formulations |
| 01/08/1998 | CA2259309A1 Steroid bisphosphonates |
| 01/08/1998 | CA2259298A1 Virginiamycin mixture |
| 01/08/1998 | CA2259233A1 Hydrophobic preparations containing medium chain monoglycerides |
| 01/08/1998 | CA2259139A1 Cationic polymer and lipoprotein-containing system for gene delivery |
| 01/08/1998 | CA2258516A1 Conjugates of thrombin inhibitors and endogenes carriers |
| 01/08/1998 | CA2258286A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/07/1998 | EP0816413A2 Purified polylactide and pharmaceutical composition thereof |
| 01/07/1998 | EP0816381A1 Peg-modified hgf |
| 01/07/1998 | EP0815872A2 Compounds for targeting |
| 01/07/1998 | EP0815871A1 A percutaneous absorption, a tape plaster and a method of promoting percutaneous absorption |
| 01/07/1998 | EP0815869A1 Method of preventing tpo adsorption and stable tpo-containing composition |
| 01/07/1998 | EP0815864A1 Semi-solid composition containing an antiflatulent agent |
| 01/07/1998 | EP0815855A1 Multiphase soft gelatin dosage form |
| 01/07/1998 | EP0815854A1 Artificial hip joint acetabular cup having two shells and its manufacture |
| 01/07/1998 | EP0815853A2 Sustained-release preparation for bioactive substance having an acidic group |
| 01/07/1998 | EP0815848A1 Use in cosmetics of copolymers with a flexible backbone, grafted with hydrophobic and rigid macromonomers; compositions using same |
| 01/07/1998 | EP0815845A1 Cosmetic and/or dermatological acidic composition containing a crosslinked and at least 90% neutralized polymer of 2-acrylamide-2-methylpropane sulfonic acid |
| 01/07/1998 | EP0815844A1 Topical surfactant-free oil-in-water emulsion containing a crosslinked neutralized polymer of 2-acrylamide-2-methylpropane sulfonic acid |
| 01/07/1998 | EP0815832A2 Kit for pharmaceutical preparations for dent and mouth care |
| 01/07/1998 | EP0815212A1 Novel encapsulation process by a gelling polymer |
| 01/07/1998 | EP0815135A1 Lipophilic peptide hormone derivatives |
| 01/07/1998 | EP0814899A1 Composition for stabilizing a suspension and pharmaceutical uses of said composition and of said suspension |
| 01/07/1998 | EP0814844A2 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
| 01/07/1998 | EP0814843A2 Hapten-carrier conjugates for use in drug-abuse therapy |
| 01/07/1998 | EP0814842A1 Method for treating amyloidosis |
| 01/07/1998 | EP0814841A2 Hcg liquid formulations |
| 01/07/1998 | EP0814836A1 Vaccine adjuvants |
| 01/07/1998 | EP0814835A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition |
| 01/07/1998 | EP0814833A1 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
| 01/07/1998 | EP0814815A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 01/07/1998 | EP0814800A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 01/07/1998 | EP0814787A1 Oil in water emulsions containing propofol and edetate |
| 01/07/1998 | EP0814782A1 Pharmaceutical composition stabilized with a basic agent |
| 01/07/1998 | EP0814781A1 Long-shelf-life medicaments |
| 01/07/1998 | EP0814780A1 Diltiazem controlled release formulation |
| 01/07/1998 | EP0814779A1 Novel encapsulation compositions and methods |
| 01/07/1998 | EP0814778A1 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
| 01/07/1998 | EP0814774A1 Reduction of adhesions using controlled delivery of active oxygen inhibitors |
| 01/07/1998 | EP0814771A1 Improvements in or relating to organic compositions |
| 01/07/1998 | EP0814766A1 Cosmetic and/or pharmaceutical preparations |
| 01/07/1998 | EP0814751A1 Coolant compositions |
| 01/07/1998 | EP0652773B1 The use of nor- and homo- bile acids derivatives as absorption enhancers for medicaments |
| 01/07/1998 | EP0633766B1 Moisturizer |
| 01/07/1998 | EP0539442B1 Enzyme inactivators |
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/07/1998 | CN1036923C Use of dehydrated trehalose as drying agent |
| 01/06/1998 | US5705655 Compounds used to produce liposomes useful as carriers for delivering macromolecules intracellularly |
| 01/06/1998 | US5705489 Having antithrombotic activity |
| 01/06/1998 | US5705485 Gel formulations containing growth factors |
| 01/06/1998 | US5705483 Glucagon-like insulinotropic peptides, compositions and methods |
| 01/06/1998 | US5705335 Design of drugs involving receptor-ligand-DNA interactions |
| 01/06/1998 | US5705270 Microcapsules prepared from crosslinkable polysaccharides, polycations and/or lipids and use therefor |
| 01/06/1998 | US5705195 Drug delivery into blood for cardiovascular disorders |
| 01/06/1998 | US5705194 Bioavailability, nose, mouth, eyes |
| 01/06/1998 | US5705190 Comprising water soluble alginate, complex salt of alginic acid, and organic carboxylic acid; with clarithromycin |
| 01/06/1998 | US5705189 Thermoplastic material for drug coatings which dissolve in intestinal juices |
| 01/06/1998 | US5705188 Lipid mixture, antitumor agents |
| 01/06/1998 | US5705187 Compositions of lipids and stabilizing materials |
| 01/06/1998 | US5705185 Prevention degradation of estradiol during permeation |
| 01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 01/06/1998 | US5705167 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders |
| 01/06/1998 | US5705158 Kits with antileukocyte antibody conjugates |
| 01/06/1998 | US5705153 Glucocerebrosidase conjugate and polyoxyalkylene oxide strands |
| 01/06/1998 | US5704297 Dry powder composition of hydroxyethyl starch suitable for reconstitution |
| 01/02/1998 | DE19624426A1 Magnetic particle for transport of diagnostic or therapeutic agent |
| 12/31/1997 | WO1997049726A1 Recombinant ribosomal inhibitor protein (rip) and use as immunoconjugate |
| 12/31/1997 | WO1997049670A1 New synthetic catechol derivatives, method for production and use thereof |
| 12/31/1997 | WO1997049431A2 Use of oligosaccharides for neutralising e. coli toxins |
| 12/31/1997 | WO1997049405A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | WO1997049402A1 Sustained release sufentanil compositions |
| 12/31/1997 | WO1997049394A2 Sold oral dosage forms of valsartan |
| 12/31/1997 | WO1997049386A1 Oral delivery of peptides |
| 12/31/1997 | WO1997049383A1 Antibacterial composition |
| 12/31/1997 | WO1997049335A1 Novel radiopharmaceutical compositions and matrices and uses thereof |
| 12/31/1997 | WO1997038726A3 Hydrophobic carbomer complex compositions |
| 12/31/1997 | CN1169115A Liposomes containing a corticosteroid |
| 12/31/1997 | CN1169114A Sequestration agents |
| 12/31/1997 | CN1169113A Solubilisation aids for hydrophilic macromolecules |
| 12/31/1997 | CN1168792A Matrix table allowing prolonged release of sodium salt of tianeptine after administration by oral route |
| 12/31/1997 | CA2258199A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | CA2252809A1 New synthetic catechol derivatives, method for production and use thereof |
| 12/31/1997 | CA2243118A1 Use of oligosaccharides for neutralising e. coli toxins |
| 12/31/1997 | CA2231732A1 Sustained release sufentanil compositions |
| 12/30/1997 | US5703200 Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer |
| 12/30/1997 | US5703126 Amphiphilic fluorine derivatives with telomeric structures |
| 12/30/1997 | US5703123 Method for causing a physiological cooling effect to the skin or mucosa involving the application of carbonic acid esters |
| 12/30/1997 | US5703101 Composition for treatment of dependency on cocaine or amphetamines comprising bromocriptine agonist and fluphenazine antagonist in amounts to preclude intoxication or overdosing and reduce satisfaction and withdrawal symptoms |
| 12/30/1997 | US5703080 Method for stabilizing duocarmycin derivatives |
| 12/30/1997 | US5703063 Phosphocholine conjugated steroid and carrier or diluent; increased bioavailability |
| 12/30/1997 | US5703051 Therapeutic uses of melanin |
| 12/30/1997 | US5702727 Compositions and methods for the oral delivery of active agents |
| 12/30/1997 | US5702724 Compressing inclusion compound containing diclofenac or salt and cyclodextrin into tablets |
| 12/30/1997 | US5702717 Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers |
| 12/30/1997 | US5702716 Polymeric compositions useful as controlled release implants |
| 12/30/1997 | US5702709 Containing organophilic clay |
| 12/30/1997 | US5702688 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |